ESR1 and breast cancer: Then, we performed univariate and multivariate analyses in ERα-positive breast cancer patients, which identified LLGL2low/SLC7A5low as an independent favorable prognostic factor for both DFS and OS, as well as lymph node negativity (Table 2).